Matches in Wikidata for { <http://www.wikidata.org/entity/Q92017003> ?p ?o ?g. }
Showing items 1 to 54 of
54
with 100 items per page.
- Q92017003 description "artículu científicu espublizáu n'abril de 2020" @default.
- Q92017003 description "im April 2020 veröffentlichter wissenschaftlicher Artikel" @default.
- Q92017003 description "scientific article published on 17 April 2020" @default.
- Q92017003 description "wetenschappelijk artikel" @default.
- Q92017003 description "наукова стаття, опублікована 17 квітня 2020" @default.
- Q92017003 name "R-DHA-oxaliplatin (R-DHAOx) versus R-DHA-cisplatin (R-DHAP) regimen in B-cell lymphoma treatment" @default.
- Q92017003 name "R-DHA-oxaliplatin (R-DHAOx) versus R-DHA-cisplatin (R-DHAP) regimen in B-cell lymphoma treatment" @default.
- Q92017003 type Item @default.
- Q92017003 label "R-DHA-oxaliplatin (R-DHAOx) versus R-DHA-cisplatin (R-DHAP) regimen in B-cell lymphoma treatment" @default.
- Q92017003 label "R-DHA-oxaliplatin (R-DHAOx) versus R-DHA-cisplatin (R-DHAP) regimen in B-cell lymphoma treatment" @default.
- Q92017003 prefLabel "R-DHA-oxaliplatin (R-DHAOx) versus R-DHA-cisplatin (R-DHAP) regimen in B-cell lymphoma treatment" @default.
- Q92017003 prefLabel "R-DHA-oxaliplatin (R-DHAOx) versus R-DHA-cisplatin (R-DHAP) regimen in B-cell lymphoma treatment" @default.
- Q92017003 P1433 Q92017003-62B5917F-F918-4AF5-BD9B-9BDCBF1DAAA1 @default.
- Q92017003 P1476 Q92017003-F097CA85-019D-492B-84F2-920F8F13D35B @default.
- Q92017003 P2093 Q92017003-0D609229-221E-40BC-859C-4E63F18E960B @default.
- Q92017003 P2093 Q92017003-24414EC9-4DCB-456B-84A3-CCD03FC04CB0 @default.
- Q92017003 P2093 Q92017003-29B64B87-90B4-4749-AAE4-3583796C1FA3 @default.
- Q92017003 P2093 Q92017003-2B7B8FC4-D075-482F-A2BA-BDFF5ED4792A @default.
- Q92017003 P2093 Q92017003-4B49ADDD-EE99-4DE9-939C-2F8A5D592E61 @default.
- Q92017003 P2093 Q92017003-5CE9D90E-4454-4CBB-A054-CD12AF6707E1 @default.
- Q92017003 P2093 Q92017003-950FF634-2E42-406A-B85D-9D5E490B5210 @default.
- Q92017003 P2093 Q92017003-ACD70842-C9C4-49A8-9EA0-E3BB7BB2CF90 @default.
- Q92017003 P2093 Q92017003-BC801E18-C145-4987-85C5-5C55D262F334 @default.
- Q92017003 P2093 Q92017003-C10F9EE9-11B0-452E-A3C7-E7BCCBEFE109 @default.
- Q92017003 P2093 Q92017003-E79C9626-14C0-47B8-9784-74748974A84A @default.
- Q92017003 P2093 Q92017003-FEFC38FD-923E-4CDD-9B83-8FE418D971B5 @default.
- Q92017003 P31 Q92017003-F029703C-E21E-4319-975A-3723652F1CEE @default.
- Q92017003 P356 Q92017003-270C1A63-2E5D-46B7-BBDD-49350552D2CB @default.
- Q92017003 P577 Q92017003-BB50450B-2F3C-4E07-8B48-C69D7842AAC5 @default.
- Q92017003 P698 Q92017003-F739C99E-BB61-4D01-9613-8BA94623C093 @default.
- Q92017003 P921 Q92017003-D1D4294E-4D08-4779-94A9-D271A91CCFD6 @default.
- Q92017003 P921 Q92017003-E0278695-B46C-402F-B5DF-6A0909C17A4E @default.
- Q92017003 P356 EJH.13429 @default.
- Q92017003 P698 32302426 @default.
- Q92017003 P1433 Q15765799 @default.
- Q92017003 P1476 "R-DHA-oxaliplatin (R-DHAOx) versus R-DHA-cisplatin (R-DHAP) regimen in B-cell lymphoma treatment" @default.
- Q92017003 P2093 "A Clavert" @default.
- Q92017003 P2093 "A Tanguy-Schmidt" @default.
- Q92017003 P2093 "C Lacout" @default.
- Q92017003 P2093 "C Orvain" @default.
- Q92017003 P2093 "J Farhi" @default.
- Q92017003 P2093 "M De Vries" @default.
- Q92017003 P2093 "M Hunault-Berger" @default.
- Q92017003 P2093 "M Mercier" @default.
- Q92017003 P2093 "M-P Moles" @default.
- Q92017003 P2093 "N Ifrah" @default.
- Q92017003 P2093 "S Thepot" @default.
- Q92017003 P2093 "V Seegers" @default.
- Q92017003 P31 Q13442814 @default.
- Q92017003 P356 "10.1111/EJH.13429" @default.
- Q92017003 P577 "2020-04-17T00:00:00Z" @default.
- Q92017003 P698 "32302426" @default.
- Q92017003 P921 Q422327 @default.
- Q92017003 P921 Q4833719 @default.